Home  »  Companies   »  Cabaletta Bio Inc Forecast: Reassessing The Past...

Cabaletta Bio Inc Forecast: Reassessing The Past

Cabaletta Bio Inc (NASDAQ:CABA) concluded the trading at $25.00 Friday, February 09 with a fall of -1.50% from its closing price on previous day.

Taking a look at stock we notice that its last check on previous day was $25.38 and 5Y monthly beta was reading 2.47 . Considering stock’s 52-week price range provides that CABA hit a high price of $26.35 and saw its price falling to a low level of $5.88 during that period. Over a period of past 1-month, stock came adding 11.41% in its value.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

With its current market valuation of $1.07 billion, Cabaletta Bio Inc is set to declare its quarterly results on Mar 14, 2024 – Mar 18, 2024. Analysts are in estimates of -$0.39 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to -$1.6 for 2023 with estimates of that growing to -$1.72 in next year. These estimates are suggesting current year growth of 11.60% for EPS and -7.50% growth next year.

In last 7 days, analysts came adjusting their opinions about stock’s EPS with no upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement. In contrast, when we review CABA stock’s current outlook then short term indicators are assigning it an average of 100% Buy, while medium term indicators are categorizing the stock at an average of 100% Buy. Long term indicators are suggesting an average of 100% Buy for it.

Digging deeper we become aware of the PEG ratio of the CABA stock which is currently positioned at 0. It further provides that stock’s current price level is 15.71% away from its 20-day simple moving average and is 21.83% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 65.08 while volatility remained at 7.65% over the past week which changes to 7.04% when measuring it over the past month. Beta is valued at 2.49, while measure of average true range or ATR is currently at 1.56.

Having a second look at Cabaletta Bio Inc (NASDAQ:CABA) provides that stock’s average daily trading volume for 3 months was 1.31 million, while it jumped to 1.03 million when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 42.85 million.

The percentage of outstanding shares held by the insiders is 19.63% while it is 83.98% for the institutional holders. The figures also indicate that as of Jan 12, 2024, number of stock’s short shares was 6.42 million which implies a short ratio of 5.53. This shows up a 14.98% of Short Interest in company’s outstanding shares on the day. In January the standing of shares short improved as it was 5.63 million in the previous month. Addition of 10.13% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.